T34	Exp 280 284	both
T35	Exp 337 347	each other
T36	Exp 352 366	the SH2 domain
T37	Exp 536 538	we
T38	Exp 612 623	its binding
T39	Exp 544 548	that
T40	Exp 632 636	both
T41	Exp 523 534	this report
T42	Exp 681 683	we
T43	Exp 758 775	their cooperation
T44	Exp 694 698	that
T45	Exp 699 714	the interaction
T46	Exp 817 834	the two molecules
T47	Exp 1001 1005	both
T48	Exp 948 970	the Jurkat T cell line
T49	Exp 983 997	the activities
T50	Exp 1318 1322	that
T51	Exp 1323 1334	the synergy
T52	Exp 1402 1417	the cooperation
T53	Exp 1295 1309	These findings
T54	SPAN 265 279	SLP-76 and Vav
R8	Coref Anaphora:T34 Antecedent:T54
T55	SPAN 265 279	SLP-76 and Vav
R9	Coref Anaphora:T35 Antecedent:T55
R10	Coref Anaphora:T38 Antecedent:T13
T56	SPAN 588 630	SLP-76 are required for its binding to Vav
R11	Coref Anaphora:T40 Antecedent:T56
T57	SPAN 723 737	SLP-76 and Vav
R12	Coref Anaphora:T43 Antecedent:T57
T58	SPAN 723 737	SLP-76 and Vav
R13	Coref Anaphora:T46 Antecedent:T58
T59	SPAN 734 944	Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 gene expression. Overexpression of SLP-76
R14	Coref Anaphora:T47 Antecedent:T59
T1	Protein 0 6	SLP-76
T2	Protein 11 14	Vav
T3	Protein 73 86	interleukin-2
T4	Protein 107 113	SLP-76
T5	Protein 118 121	Vav
T6	Protein 265 271	SLP-76
T7	Protein 276 279	Vav
T8	Protein 370 373	Vav
T9	Protein 406 412	SLP-76
T10	Protein 427 433	SLP-76
T11	Protein 438 441	Vav
T12	Protein 471 489	interleukin (IL)-2
T13	Protein 588 594	SLP-76
T14	Protein 627 630	Vav
T15	Protein 723 729	SLP-76
T16	Protein 734 737	Vav
T17	Protein 790 794	IL-2
T18	Protein 898 902	IL-2
T19	Protein 938 944	SLP-76
T20	Protein 1105 1108	Vav
T21	Protein 1228 1231	Vav
T22	Protein 1241 1247	SLP-76
T23	Protein 1258 1262	CD28
T24	Protein 1271 1275	IL-2
T25	Protein 1343 1349	SLP-76
T26	Protein 1354 1357	Vav
T27	Protein 1372 1376	IL-2
